Click for best price
Urinary Tract Cancer Market Size, Share 2023
One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly occurent cancer types in 2012 and have high reoccurrence rate as well.
This report aims to provide a comprehensive presentation of the global market for Urinary Tract Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Tract Cancer. This report contains market size and forecasts of Urinary Tract Cancer in global, including the following market information:
Global Urinary Tract Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Urinary Tract Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major factors favoring the growth of the urinary tract cancer treatment market are increasing incidence of urinary tract cancer worldwide owing to rising sedentary lifestyle, geriatric population, rising smoking population and rigorous research activities towards developing urinary tract cancer therapeutics. Clinical trial review of the therapeutics to treat urinary tract cancer seems to provide a lucrative growth prospects for this market.
We surveyed the Urinary Tract Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urinary Tract Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Urinary Tract Cancer Market Segment Percentages, by Type, 2022 (%)
Urothelial Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
Others
Global Urinary Tract Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Urinary Tract Cancer Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Research Centers
Others
Global Urinary Tract Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Urinary Tract Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urinary Tract Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Urinary Tract Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Spectrum Pharmaceuticals Boehringer Ingelheim
Bristol-Myers Squibb Company
Genzyme Corporation
F. Hoffmann-La Roche
Shionogi
Kyowa Hakko Kirin
Medical Enzymes
IkerChem
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urinary Tract Cancer, market overview.
Chapter 2: Global Urinary Tract Cancer market size in revenue.
Chapter 3: Detailed analysis of Urinary Tract Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urinary Tract Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Urinary Tract Cancer Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Urinary Tract Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Urinary Tract Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urinary Tract Cancer Overall Market Size
2.1 Global Urinary Tract Cancer Market Size: 2022 VS 2029
2.2 Global Urinary Tract Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Urinary Tract Cancer Players in Global Market
3.2 Top Global Urinary Tract Cancer Companies Ranked by Revenue
3.3 Global Urinary Tract Cancer Revenue by Companies
3.4 Top 3 and Top 5 Urinary Tract Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Urinary Tract Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Urinary Tract Cancer Players in Global Market
3.6.1 List of Global Tier 1 Urinary Tract Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Urinary Tract Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Urinary Tract Cancer Market Size Markets, 2022 & 2029
4.1.2 Urothelial Carcinoma
4.1.3 Squamous Cell Carcinoma
4.1.4 Adenocarcinoma
4.1.5 Others
4.2 By Type - Global Urinary Tract Cancer Revenue & Forecasts
4.2.1 By Type - Global Urinary Tract Cancer Revenue, 2018-2023
4.2.2 By Type - Global Urinary Tract Cancer Revenue, 2024-2029
4.2.3 By Type - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Urinary Tract Cancer Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Centers
5.1.5 Others
5.2 By Application - Global Urinary Tract Cancer Revenue & Forecasts
5.2.1 By Application - Global Urinary Tract Cancer Revenue, 2018-2023
5.2.2 By Application - Global Urinary Tract Cancer Revenue, 2024-2029
5.2.3 By Application - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Urinary Tract Cancer Market Size, 2022 & 2029
6.2 By Region - Global Urinary Tract Cancer Revenue & Forecasts
6.2.1 By Region - Global Urinary Tract Cancer Revenue, 2018-2023
6.2.2 By Region - Global Urinary Tract Cancer Revenue, 2024-2029
6.2.3 By Region - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Urinary Tract Cancer Revenue, 2018-2029
6.3.2 US Urinary Tract Cancer Market Size, 2018-2029
6.3.3 Canada Urinary Tract Cancer Market Size, 2018-2029
6.3.4 Mexico Urinary Tract Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Urinary Tract Cancer Revenue, 2018-2029
6.4.2 Germany Urinary Tract Cancer Market Size, 2018-2029
6.4.3 France Urinary Tract Cancer Market Size, 2018-2029
6.4.4 U.K. Urinary Tract Cancer Market Size, 2018-2029
6.4.5 Italy Urinary Tract Cancer Market Size, 2018-2029
6.4.6 Russia Urinary Tract Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Urinary Tract Cancer Market Size, 2018-2029
6.4.8 Benelux Urinary Tract Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Urinary Tract Cancer Revenue, 2018-2029
6.5.2 China Urinary Tract Cancer Market Size, 2018-2029
6.5.3 Japan Urinary Tract Cancer Market Size, 2018-2029
6.5.4 South Korea Urinary Tract Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Urinary Tract Cancer Market Size, 2018-2029
6.5.6 India Urinary Tract Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Urinary Tract Cancer Revenue, 2018-2029
6.6.2 Brazil Urinary Tract Cancer Market Size, 2018-2029
6.6.3 Argentina Urinary Tract Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Urinary Tract Cancer Revenue, 2018-2029
6.7.2 Turkey Urinary Tract Cancer Market Size, 2018-2029
6.7.3 Israel Urinary Tract Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Urinary Tract Cancer Market Size, 2018-2029
6.7.5 UAE Urinary Tract Cancer Market Size, 2018-2029
7 Urinary Tract Cancer Companies Profiles
7.1 Spectrum Pharmaceuticals Boehringer Ingelheim
7.1.1 Spectrum Pharmaceuticals Boehringer Ingelheim Company Summary
7.1.2 Spectrum Pharmaceuticals Boehringer Ingelheim Business Overview
7.1.3 Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Major Product Offerings
7.1.4 Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.1.5 Spectrum Pharmaceuticals Boehringer Ingelheim Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Urinary Tract Cancer Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 Genzyme Corporation
7.3.1 Genzyme Corporation Company Summary
7.3.2 Genzyme Corporation Business Overview
7.3.3 Genzyme Corporation Urinary Tract Cancer Major Product Offerings
7.3.4 Genzyme Corporation Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.3.5 Genzyme Corporation Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Urinary Tract Cancer Major Product Offerings
7.4.4 F. Hoffmann-La Roche Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Shionogi
7.5.1 Shionogi Company Summary
7.5.2 Shionogi Business Overview
7.5.3 Shionogi Urinary Tract Cancer Major Product Offerings
7.5.4 Shionogi Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.5.5 Shionogi Key News & Latest Developments
7.6 Kyowa Hakko Kirin
7.6.1 Kyowa Hakko Kirin Company Summary
7.6.2 Kyowa Hakko Kirin Business Overview
7.6.3 Kyowa Hakko Kirin Urinary Tract Cancer Major Product Offerings
7.6.4 Kyowa Hakko Kirin Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.6.5 Kyowa Hakko Kirin Key News & Latest Developments
7.7 Medical Enzymes
7.7.1 Medical Enzymes Company Summary
7.7.2 Medical Enzymes Business Overview
7.7.3 Medical Enzymes Urinary Tract Cancer Major Product Offerings
7.7.4 Medical Enzymes Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.7.5 Medical Enzymes Key News & Latest Developments
7.8 IkerChem
7.8.1 IkerChem Company Summary
7.8.2 IkerChem Business Overview
7.8.3 IkerChem Urinary Tract Cancer Major Product Offerings
7.8.4 IkerChem Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.8.5 IkerChem Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Urinary Tract Cancer Major Product Offerings
7.9.4 Amgen Urinary Tract Cancer Revenue in Global Market (2018-2023)
7.9.5 Amgen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Urinary Tract Cancer Market Opportunities & Trends in Global Market
Table 2. Urinary Tract Cancer Market Drivers in Global Market
Table 3. Urinary Tract Cancer Market Restraints in Global Market
Table 4. Key Players of Urinary Tract Cancer in Global Market
Table 5. Top Urinary Tract Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Urinary Tract Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Urinary Tract Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Urinary Tract Cancer Product Type
Table 9. List of Global Tier 1 Urinary Tract Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Urinary Tract Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Urinary Tract Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Urinary Tract Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Urinary Tract Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Urinary Tract Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Urinary Tract Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Urinary Tract Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Urinary Tract Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Urinary Tract Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Urinary Tract Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Urinary Tract Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Urinary Tract Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Urinary Tract Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Urinary Tract Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Urinary Tract Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Urinary Tract Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Urinary Tract Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Urinary Tract Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Urinary Tract Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Urinary Tract Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Spectrum Pharmaceuticals Boehringer Ingelheim Company Summary
Table 31. Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Product Offerings
Table 32. Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Spectrum Pharmaceuticals Boehringer Ingelheim Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Company Summary
Table 35. Bristol-Myers Squibb Company Urinary Tract Cancer Product Offerings
Table 36. Bristol-Myers Squibb Company Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Company Key News & Latest Developments
Table 38. Genzyme Corporation Company Summary
Table 39. Genzyme Corporation Urinary Tract Cancer Product Offerings
Table 40. Genzyme Corporation Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Genzyme Corporation Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Company Summary
Table 43. F. Hoffmann-La Roche Urinary Tract Cancer Product Offerings
Table 44. F. Hoffmann-La Roche Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. F. Hoffmann-La Roche Key News & Latest Developments
Table 46. Shionogi Company Summary
Table 47. Shionogi Urinary Tract Cancer Product Offerings
Table 48. Shionogi Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Shionogi Key News & Latest Developments
Table 50. Kyowa Hakko Kirin Company Summary
Table 51. Kyowa Hakko Kirin Urinary Tract Cancer Product Offerings
Table 52. Kyowa Hakko Kirin Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Kyowa Hakko Kirin Key News & Latest Developments
Table 54. Medical Enzymes Company Summary
Table 55. Medical Enzymes Urinary Tract Cancer Product Offerings
Table 56. Medical Enzymes Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Medical Enzymes Key News & Latest Developments
Table 58. IkerChem Company Summary
Table 59. IkerChem Urinary Tract Cancer Product Offerings
Table 60. IkerChem Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. IkerChem Key News & Latest Developments
Table 62. Amgen Company Summary
Table 63. Amgen Urinary Tract Cancer Product Offerings
Table 64. Amgen Urinary Tract Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Amgen Key News & Latest Developments
List of Figures
Figure 1. Urinary Tract Cancer Segment by Type in 2022
Figure 2. Urinary Tract Cancer Segment by Application in 2022
Figure 3. Global Urinary Tract Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Urinary Tract Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Urinary Tract Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Urinary Tract Cancer Revenue in 2022
Figure 8. By Type - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Urinary Tract Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Urinary Tract Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 16. US Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 28. China Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Urinary Tract Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Urinary Tract Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Spectrum Pharmaceuticals Boehringer Ingelheim Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Company Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genzyme Corporation Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. F. Hoffmann-La Roche Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Shionogi Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Kyowa Hakko Kirin Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Medical Enzymes Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. IkerChem Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amgen Urinary Tract Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
